Nyrada Inc -Phase I Clinical Trial Dosing Update #1

Highlights:
•Nyrada’s Phase I clinical trial Safety Review Committee (SRC) has considered safety and pharmacokinetic data from first dosed cohort.
•SRC raised no issues enabling the clinical trial proceeding to second cohort.